Offer - Urjas Oil for just ₹ 1
Mycamine is a prescription medicine that is available as a Injection. It is typically used for the treatment of Fungal Infections. Mycamine also has some secondary and off-label uses. These are listed below.
Medical history of the patient along with age and gender determines the dosage of Mycamine. Besides the medical condition it is advised for, the route of administration also plays an important role in determining the correct drug dosage. Detailed information has been provided in the dosage section.
Mycamine also has some side effects, the most common being Decreased potassium level in blood, Decreased Calcium Level. Apart from the aforementioned side effects, Mycamine can also lead to other problems, which have been listed below. Normally, these side effects of Mycamine are not long lasting and go away when the treatment is finished. Consult your doctor if these side effects become worse or stay for a longer duration.
Furthermore, you should know that effect of Mycamine is Moderate for pregnant women and Moderate for women who are breastfeeding. Further, the section on Mycamine related warnings talks about Mycamine's effects on the liver, heart and kidney.
The section on Mycamine contraindications lists all such conditions.
Drug interactions for Mycamine have been reported in the medical literature. A complete list of these interactions is given below.
In addition to the above precautions for Mycamine, it is important to know that it is safe while driving, and is habit-forming.
Mycamine is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
| Age Group | Dosage |
| Adult |
|
| Geriatric |
|
| 13 - 18 years (Adolescent) |
|
| 2 - 12 years (Child) |
|
| Infant (1 month to 2 years) |
|
Is the use of Mycamine safe for pregnant women?
Mycamine can cause unwanted side effects in pregnant women. If you experience any side effects, stop taking Mycamine right away. Take your doctor's advice before taking it again.
Is the use of Mycamine safe during breastfeeding?
Women who are breastfeeding can experience some moderate side effects of Mycamine. Immediately discontinue Mycamine if you observe any side effects. Contact your doctor, and restart using it only if your doctor considers it safe for you.
What is the effect of Mycamine on the Kidneys?
Mycamine rarely harms the kidneys.
What is the effect of Mycamine on the Liver?
Very few cases of side effects of Mycamine on the liver have been reported.
What is the effect of Mycamine on the Heart?
There are no any side effects of Mycamine for the heart.
Mycamine should not be taken with following medicines due to severe side effects it may cause to patients -
Moderate
If you are suffering from any of the following diseases, you should not take Mycamine unless your doctor advises you to do so -
Is this Mycamine habit forming or addictive?
No, you will not get addicted to Mycamine.
Is it safe to drive or operate heavy machinery when consuming?
Mycamine does not cause dizziness or sleep, so you can drive a vehicle or operate machinery also.
Is it safe?
Mycamine is safe but it is important to consult a doctor before taking it.
Is it able to treat mental disorders?
There is no benefit of taking Mycamine for mental disorders.
Interaction between Food and Mycamine
It is safe to take Mycamine with food.
Interaction between Alcohol and Mycamine
Information about the interaction of Mycamine and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Mycamine® (micafungin sodium)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 852-854
